EASD 2021: High-Dose Semaglutide Safely Promotes Diabetes Control and Weight Loss in Type 2 Diabetes
Findings were often superior to those found with the lower dose
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.